New hope for IBS-D sufferers: ramosetron trial aims to tame diarrhea and pain
Symptom relief
Not yet recruiting
This study tests whether the drug ramosetron can reduce belly pain, bloating, and diarrhea in people with diarrhea-predominant irritable bowel syndrome (IBS-D). About 76 adults aged 18–65 will receive either ramosetron or a placebo daily for 4 weeks, along with a low-FODMAP diet …
Phase: PHASE4 • Sponsor: Md. Aminul Islam • Aim: Symptom relief
Last updated Jun 15, 2026 18:57 UTC